| Macrophage migration inhibitory factor inhibition as a novel therapeutic approach against triple-negative breast cancer M Charan, S Das, S Mishra, N Chatterjee, S Varikuti, K Kaul, S Misri, ... Cell Death & Disease 11 (9), 774, 2020 | 52 | 2020 |
| Cannabidiol inhibits tumorigenesis in cisplatin-resistant non-small cell lung cancer via TRPV2 S Misri, K Kaul, S Mishra, M Charan, AK Verma, MP Barr, DK Ahirwar, ... Cancers 14 (5), 1181, 2022 | 34 | 2022 |
| cPLA2 blockade attenuates S100A7-mediated breast tumorigenicity by inhibiting the immunosuppressive tumor microenvironment S Mishra, M Charan, RK Shukla, P Agarwal, S Misri, AK Verma, ... Journal of Experimental & Clinical Cancer Research 41 (1), 54, 2022 | 25 | 2022 |
| Molecular and cellular factors associated with racial disparity in breast cancer M Charan, AK Verma, S Hussain, S Misri, S Mishra, S Majumder, ... International journal of molecular sciences 21 (16), 5936, 2020 | 21 | 2020 |
| Contribution of the tumor and obese microenvironment to triple negative breast cancer K Kaul, S Misri, B Ramaswamy, RK Ganju Cancer Letters 509, 115-120, 2021 | 7 | 2021 |
| Slit2/Robo1 signaling inhibits small‐cell lung cancer by targeting β‐catenin signaling in tumor cells and macrophages DK Ahirwar, B Peng, M Charan, S Misri, S Mishra, K Kaul, S Sassi, ... Molecular Oncology 17 (5), 839-856, 2023 | 4 | 2023 |
| Slit2 inhibits small cell lung cancer by targeting tumor microenvironment DK Ahirwar, M Charan, S Misri, K Shilo, R Ganju Cancer Research 82 (12_Supplement), 2557-2557, 2022 | | 2022 |
| Received date: 29-Apr-2022 DK Ahirwar, B Peng, M Charan, S Misri, S Mishra, K Kaul, S Sassi, ... | | |
